AXA IM PRIME
AXA IM PRIME is a Series C+, buyout, secondary and other fund in the US, global, western-europe and asia investing in Developer Tools, Healthcare, life-science, energy-transition, digital-infrastructure and special-situations.
- Stages
- Series C+, buyout, secondary, other
- Sectors
- Developer Tools, Healthcare, life-science, energy-transition, digital-infrastructure, special-situations
- Invests in
- US-wide, global, western-europe, asia
- Actively investing
- Yes
- Founded
- 2022
- Assets under management
- $37B
Check size not disclosed
Thesis
AXA IM PRIME, the private capital arm of AXA IM formed in 2022, manages approximately $37 billion in assets as of December 2023. The firm operates as a 'private markets enabler' and hedge funds platform, providing commingled and tailored investment solutions through partnerships with fund managers. Their strategy focuses on a 'one-stop-shop' approach, creating customized solutions for LPs and GPs, with an emphasis on acquiring minority equity stakes in private markets asset managers. They invest globally, with a focus on North America and Western Europe for infrastructure, and have increased exposure to Asia-focused hedge funds. Key sectors of interest include Biotech/life science, energy transition, and digital infrastructure. They also engage in Equity Special Situations. The firm's investment activities span primaries, secondaries, co-investments, NAV financing, and GP stakes, supporting long-term sustainable growth with ESG commitments. The AXA IM Prime GP Stakes Fund is valued at $636 million, and their debut secondaries infrastructure fund targeted €1 billion after a first close of €430 million in April 2024.
Common questions
Does AXA IM PRIME invest at the Series C+ stage?
Yes. AXA IM PRIME lists Series C+, buyout, secondary and other among the stages it invests in.
Where does AXA IM PRIME invest?
AXA IM PRIME invests in the US, global, western-europe and asia.